| [1] |
SU Ya, ZHANG Dongwei, YU Minghui, WANG Chunhua, WU Yueyue.
Observation on the clinical efficacy of compound kushen injection combined with targeted and immune therapy in the treatment of advanced hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2026, 54(3): 324-328.
|
| [2] |
HUANG Huiqi, WU Qiuyuan, ZHANG Kun, LI Peixian, XIONG Yaming, YE Guolin, ZHOU Dan.
Research on the anti-tumor mechanism of toosendanin combined with olaparib in triple negative breast cancer
[J]. Tianjin Medical Journal, 2025, 53(9): 897-902.
|
| [3] |
WANG Chao, ZHANG Junmei, ZHANG Peng, LIU Li, WANG Xiaochun.
Comparison of efficacy of recombinant human interleukin-11 and herombopag olamine tablets on chemotherapy-induced thrombocytopenia in breast cancer
[J]. Tianjin Medical Journal, 2025, 53(4): 365-369.
|
| [4] |
LI Na, HE Ying, TENG Fei, HE Wenshu, GUO Caifeng, ZHONG Na, WU Qiong, LI Jun.
The application value of ultrasound BI-RADS classification combined with serum FGFR1 and GDF3 in the differential diagnosis of benign and malignant breast masses
[J]. Tianjin Medical Journal, 2025, 53(3): 247-251.
|
| [5] |
WANG Wei, XIA Haishui, MA Shang.
Efficacy of trastuzumab combined with neratinib in the treatment of HER-2 positive metastatic breast cancer
[J]. Tianjin Medical Journal, 2025, 53(3): 321-325.
|
| [6] |
WANG Linna, WANG Di, DONG Yanhong.
Clinical effect of aribulin combined with NP regimen in the treatment of patients with advanced breast cancer
[J]. Tianjin Medical Journal, 2025, 53(3): 326-330.
|
| [7] |
ZHAI Shupeng, JIA Hang, MIAO Tong, WEI Kangkang, ZHOU Guoping.
The relationship between serum Trx1, PDCD4, AQP4 expression and cognitive function in patients with Parkinson‘s disease
[J]. Tianjin Medical Journal, 2025, 53(2): 146-150.
|
| [8] |
HUANG Xiaoqing, LIU Yuanyuan, YAN Liang, YI Shuping.
Dosimetric comparison of two irradiation modes after radical mastectomy for breast cancer
[J]. Tianjin Medical Journal, 2025, 53(11): 1204-1207.
|
| [9] |
LIU Yuanyuan, HUANG Xiaoqing, YAN Liang, YI Shuping.
Preventive efficacy of rhGM-CSF combined with Kangfuxin liquid on radiation dermatitis of breast cancer
[J]. Tianjin Medical Journal, 2025, 53(10): 1076-1080.
|
| [10] |
MAN Yi, XU Ya, HE Xiancheng, SONG Shaofeng, LIU Aiguo.
Relationship between expression levels of EGFR, Ki-67, P53 and CTC and the prognosis of triple negative breast cancer
[J]. Tianjin Medical Journal, 2024, 52(8): 862-867.
|
| [11] |
ZHU Gangming, DONG Yongde, ZHU Ruiting, TAN Yuanman, TAO Juan, LIU Xiao, CHEN Decheng, YANG Gai.
The value of magnetic resonance relaxation time quantitative imaging in predicting molecular subtypes of invasive ductal carcinoma
[J]. Tianjin Medical Journal, 2024, 52(7): 770-774.
|
| [12] |
CHEN Zhiyan, WU Qiuyuan, DENG Yuhua, ZHOU Dan.
Status and application of organoid technology in breast cancer research
[J]. Tianjin Medical Journal, 2024, 52(6): 668-672.
|
| [13] |
LIU Danyang, LI Yongtao, ZHANG Haiyan, LI Lin, LIU Yang, SHEN Lei.
Effect of breast cancer cell conditioned medium on biological behavior of bone marrow mesenchymal stem cells
[J]. Tianjin Medical Journal, 2024, 52(5): 454-458.
|
| [14] |
LU Xinyi, DU Weipo, LI Jinggang, GUO Fangfang, ZHANG Xiaolei, LIU Jing.
Correlation between serum miR-193a-3p, ATF5 levels and chemotherapy efficacy in patients with triple negative breast cancer
[J]. Tianjin Medical Journal, 2024, 52(12): 1313-1316.
|
| [15] |
XIE Haoran, LI Yihao, LIU Cheng, XIA Yuting, QIU Shenglei, XIONG Bin, FENG Qizhen.
Research of predictive factors of axillary lymph node metastasis in breast cancer under the context of DIP payment of medical insurance
[J]. Tianjin Medical Journal, 2024, 52(11): 1193-1196.
|